Lantern Pharma Inc Share Price Today: Live Updates & Key Insights
Lantern Pharma Inc share price today is $2.17, up -1.39%. The stock opened at $2.12 against the previous close of $2.16, with an intraday high of $2.17 and low of $2.03.
Lantern Pharma Inc Share Price Chart
Lantern Pharma Inc
Lantern Pharma Inc Share Price Performance
Lantern Pharma Inc Institutional Holdings
Lantern Pharma Inc Market Status
Lantern Pharma Inc Fundamentals
Market Cap 23.82 M
PB Ratio 2.4955
PE Ratio 0.0
Enterprise Value 11.89 M
Total Assets 25.57 M
Volume 44972
Lantern Pharma Inc Company Financials
About Lantern Pharma Inc & investment objective
Company Information Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1 clinical trial for the treatment of solid tumor, such as pancreatic, breast, bladder, and lung cancers, as well as glioblastoma and other central nervous system (CNS) cancers; and LP-284, which is in phase 1 clinical trial for the treatment of non-Hodgkin's lymphomas, including mantle cell lymphoma and double hit lymphoma. The company also develops STAR-001, which is in preclinical development for the treatment of glioblastoma, brain metastases, atypical teratoid rhabdoid tumors, and several rare pediatric CNS cancers. In addition, it provides ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. The company has a strategic AI-driven collaboration with Oregon Therapeutics to optimize the development of its first-in-class protein disulfide isomerase inhibitor drug candidate XCE853 in novel and targeted cancer indications; a collaboration agreement with TTC Oncology, which focuses on the drug development of TTC-352 to treat patients with metastatic ER+ breast cancer; and a collaboration agreement with Actuate Therapeutics, Inc. that focuses on the development of compounds for use in the treatment of cancer and inflammatory diseases. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Organisation Biotechnology
Employees 24
Industry Biotechnology
CEO Mr. Panna Sharma
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Lantern Pharma Inc FAQs
What is the share price of Lantern Pharma Inc today?
The current share price of Lantern Pharma Inc is $2.17.
Can I buy Lantern Pharma Inc shares in India?
Yes, Indian investors can buy Lantern Pharma Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Lantern Pharma Inc shares in India?
You can easily invest in Lantern Pharma Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Lantern Pharma Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Lantern Pharma Inc.
Can I buy fractional shares of Lantern Pharma Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Lantern Pharma Inc?
Lantern Pharma Inc has a market cap of $23.82 M.
In which sector does Lantern Pharma Inc belong?
Lantern Pharma Inc operates in the Biotechnology sector.
What documents are required to invest in Lantern Pharma Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Lantern Pharma Inc?
The PE ratio of Lantern Pharma Inc is N/A and the PB ratio is 2.50.